These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38335130)

  • 21. Diagnostic efficacy of serum and urinary netrin-1 in the early detection of diabetic nephropathy.
    Elkholy RA; Younis RL; Allam AA; Hagag RY; Abdel Ghafar MT
    J Investig Med; 2021 Aug; 69(6):1189-1195. PubMed ID: 33863755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of certain urinary microRNAs as promising biomarkers in diabetic nephropathy patients using gold nanoparticles.
    Nossier AI; Shehata NI; Morsy SM; Saeed DF; Elsayed NM; Ismail MF; Eissa S
    Anal Biochem; 2020 Nov; 609():113967. PubMed ID: 32950495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
    Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
    J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies.
    Roointan A; Gheisari Y; Hudkins KL; Gholaminejad A
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2253-2272. PubMed ID: 34059383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
    Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
    Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Complement and Inflammatory Biomarkers with Diabetic Nephropathy.
    Huang H; Li D; Huang X; Wang Y; Wang S; Wang X; Yang X
    Ann Clin Lab Sci; 2019 Sep; 49(4):488-495. PubMed ID: 31471338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes.
    Zhang D; Ye S; Pan T
    PeerJ; 2019; 7():e7079. PubMed ID: 31218128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic significance of urinary transferrin in diabetic nephropathy.
    Kanauchi M; Nishioka H; Hashimoto T; Dohi K
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):649-54. PubMed ID: 8583702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
    Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Utility of Serum Cystatin C in Predicting Diabetic Nephropathy Among Patients with Diabetes Mellitus: a Meta-Analysis.
    Zhou B; Zou H; Xu G
    Kidney Blood Press Res; 2016; 41(6):919-928. PubMed ID: 27889768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of urinary osteopontin in association with podocyte for early predication of nephropathy in diabetic patients.
    Al-Malki AL
    Dis Markers; 2014; 2014():493736. PubMed ID: 24876663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
    Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
    Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients.
    Al-Rubeaan K; Siddiqui K; Al-Ghonaim MA; Youssef AM; Al-Sharqawi AH; AlNaqeb D
    Sci Rep; 2017 Jun; 7(1):2684. PubMed ID: 28577020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of Neutrophil Gelatinase-Associated Lipocalin as a Biomarker for the Diagnosis of Diabetic Kidney Disease: A Systematic Review and Meta-Analysis.
    He P; Bai M; Hu JP; Dong C; Sun S; Huang C
    Kidney Blood Press Res; 2020; 45(4):497-509. PubMed ID: 32623432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.